4.5 Letter

Double Biologic Therapy for Refractory Stricturing Crohn's Disease: A Successful Case of Deep Remission with Ustekinumab and Vedolizumab

Related references

Note: Only part of the references are listed.
Letter Gastroenterology & Hepatology

Combination Biologic Therapy in Inflammatory Bowel Disease: Experience From a Tertiary Care Center

Lukasz Kwapisz et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Colonic Phenotypes Are Associated with Poorer Response to Anti-TNF Therapies in Patients with IBD

Soon Man Yoon et al.

INFLAMMATORY BOWEL DISEASES (2017)

Review Gastroenterology & Hepatology

Crohn's disease complicated by strictures: a systematic review

Florian Rieder et al.

Article Gastroenterology & Hepatology

Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection

Miguel Regueiro et al.

GASTROENTEROLOGY (2009)

Review Gastroenterology & Hepatology

Systematic review:: Has disease outcome in Crohn's disease changed during the last four decades?

FL Wolters et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)